PellePharm, Inc. operates in the biotechnology industry. The company was incorporated in 2012 and is based in Menlo Park, California. Focused on the development of topical patidegib, a first-in-class topical hedgehog inhibitor, to decrease the number of surgically-eligible basal cell carcinomas (BCCs) in persons with Gorlin Syndrome and those with sporadic BCCs.
Menlo Park, US
Size (employees)
5 (est)
PellePharm was founded in 2012 and is headquartered in Menlo Park, US

PellePharm Office Locations

PellePharm has an office in Menlo Park
Menlo Park, US (HQ)
275 Middlefield Road

PellePharm Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$11.4 m

Latest funding size

$3.3 m

Time since last funding

over 1 year
PellePharm's latest funding round in August 2016 was reported to be $3.3 m. In total, PellePharm has raised $11.4 m

PellePharm's Web-traffic and Trends

PellePharm Company Life and Culture

You may also be interested in